First Tracks Biotherapeutics Inc (TRAX)
First Tracks Biotherapeutics Inc operates in the Biotechnology industry of the Healthcare sector, headquartered in San Diego, CA, US. The stock last traded at $41.64, down 6.34% on the session, giving a market capitalisation of $1.75B. On trailing twelve-month figures it carries a trailing P/E of -9.27, a net margin of 0.0%. Its beta of 3.37 implies it has historically moved more than the broad market.
First Tracks Biotherapeutics, Inc., situated in San Diego, California, specializes in pioneering new immunology-based treatments. The firm is actively involved in the discovery and progression of therapeutics aimed at combating autoimmune and inflammatory disorders, currently advancing programs like rosnilimab, ANB033, and ANB101 through their clinical stages.
First Tracks Biotherapeutics Inc is most often compared with the following Healthcare names: